Hormone therapy has endured a rather bumpy history after the Women’s Health Initiative published clinical trial data in 2002 ...

Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.

The FDA is reevaluating longtime warnings on hormone replacement therapy products for menopausal women. Some advocates for ...

A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...

( NewsNation) — The head of the U.S. Food and Drug Administration signaled Thursday that he supports changing or removing the ...

Sarepta Therapeutics shares surged 34% in after-hours trading on Wednesday after the company said it would slash 500 jobs, or ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. The Food and Drug Administration said Friday that it will require a ...

New data shows no increased cardiovascular risk of the osteoporosis drug vs anabolic agents — and even suggests a lower risk.

The FDA announced diabetes drugs Avandia and Actos will begin carrying a 'black box' warning, the strongest level of warning issued by the FDA after congressional hearings about the drugs' heart risks ...

Nearly 44,000 Americans died from drug overdoses in 2014, including 23,000 who overdosed on prescription drugs. About 70% of prescription drug overdoses were due to opioid painkillers, with 30% ...

Sarepta's gene therapy pipeline faces renewed scrutiny after a third patient death and FDA plans for a black box warning on ...

The U.S. Food and Drug Administration (FDA) has issued its most serious warning -- a black-box warning -- for Veozah, a medication used to relieve hot flashes in menopausal women, due to rare but ...